Another study highlighted its role on patient surveillance as well as on the detection of mechanisms of resistance in EGFR-mutated NSCLC, which was achieved by targeting shorter cfDNA fragments, which enabled the detection of the T790M mutation [189]. Here, EGFR is linked to non-small cell lung carcinoma.